Business Wire

ABB and HPE Bring Intelligence to Industrial Plants

Del

ABB and Hewlett Packard Enterprise (HPE) today announced a strategic global partnership that combines ABB’s industry-leading digital offerings, ABB AbilityTM, with HPE’s innovative hybrid information technology (IT) solutions. The partnership will provide customers with solutions that generate actionable insights from vast amounts of industrial data to increase the efficiency and flexibility of their operations and create competitive advantage.

Customers will benefit from ABB’s deep domain expertise in operations technologies (OT) and HPE’s leadership in information technologies (IT). ABB and HPE will deliver joint industry solutions that merge OT and IT to turn industrial data into insights and automatic action, combining widely-adopted cloud platforms like Microsoft Azure with IT systems running in corporate data centers and at the edge of the network. Employing the right mix of IT platforms will accelerate data processing in industrial plants and at the same time enable effective control of industrial processes across locations.

“This strategic partnership marks the next level of the digital industrial transformation. Together, we will bring intelligence from cloud-based solutions to on-premises deployments in industrial plants and data centers for greater uptime, speed and yield,” said ABB CEO Ulrich Spiesshofer. “ABB and HPE will deliver solutions that span the entire range of computing required by enterprises today, from the edge to the cloud to the core.”

With an installed base of 70 million connected devices, 70,000 digital control systems and 6,000 enterprise software solutions, ABB is a trusted leader in the industrial space, and has a four-decade-long history of creating digital solutions for customers. HPE in turn is a global leader in helping customers optimize their IT environments with secure, software-defined technologies that seamlessly integrate across traditional IT, multiple public and private clouds and the intelligent edge to drive key business outcomes.

“This alliance between two global leaders is unprecedented in terms of breadth and depth, and it will be ground-breaking for the progress of the Industrial Internet of Things,” said Meg Whitman, CEO, HPE. “Together with ABB, we will shape a digital industrial future where everything computes, equipping machines with intelligence to collaborate, allowing plants to flexibly adapt to changing demands, and enabling global supply chains to instantaneously react to incidents. This partnership will create exciting business opportunities for our joint customers.”

To provide a true end-to-end experience for customers, the ABB-HPE partnership will include co-innovation, co-development, joint go to market and service.

Research firm IDC forecasts that worldwide spending on the Internet of Things (IoT) will grow to $1.4 trillion in 2021 from an expected $800 billion in 2017. The largest investments are being made in areas such as manufacturing, transportation and utilities.1 To tap into the opportunities of the IoT, companies are investing in new solutions that digitize their industrial equipment and integrate it with their broader IT environments. By joining forces, ABB and HPE are bringing together the capabilities needed to accelerate this transformation.

Computing where it is required

Running data acquisition, analytics and control processes near industrial equipment helps customers avoid the latency, security and reliability issues associated with data communication through remote IT systems. ABB and HPE will jointly develop, market and service digital industrial solutions that help customers:

  • Create deep insights and automatic action from industrial data – by running ABB AbilityTM applications on enterprise-grade IT systems close to the industrial equipment to accelerate the processing of vast amounts of data; and
  • Manage and control industrial processes across the supply chain – by leveraging hybrid IT to provide a seamless experience from edge to cloud to core, making critical data available across locations.

The partnership will enable ABB Ability™ solutions to run on hybrid platforms such as HPE ProLiant for Microsoft Azure Stack, enabling customers to deploy applications to their preferred location – on HPE infrastructure in industrial plants and data centers or in the Microsoft Azure public cloud – to meet the specific requirements regarding performance, security or cross-site collaboration.

ABB and HPE will also deliver joint solutions for data centers, including

  • Data center automation – to enable data center power, cooling and building systems automatically adapt to changing IT demands or incidents. To that end, ABB and HPE will integrate ABB AbilityTM Data Center Automation, which controls, monitors and optimizes mission-critical data center facilities infrastructure, with HPE OneView, HPE’s IT infrastructure automation software.
  • Secure edge data center – specifically designed to run in harsh industrial environments, bringing enterprise-grade IT capacity closer to the point of data collection and machine control. This solution is being developed in collaboration between ABB, HPE and Rittal, the world’s largest manufacturer of IT racks, and will be an off-the-shelf ready IT data center solution for industrial customers enabling real-time insight and action.

The partnership was announced today at the HPE Discover conference in Madrid, where both companies demonstrated their first jointly developed solutions and prototypes.

ABB (ABBN: SIX Swiss Ex) is a pioneering technology leader in electrification products, robotics and motion, industrial automation and power grids, serving customers in utilities, industry and transport & infrastructure globally. Continuing a history of innovation spanning more than 125-years, ABB today is writing the future of industrial digitalization and driving the Energy and Fourth Industrial Revolutions. ABB operates in more than 100 countries with about 136,000 employees. www.abb.com

Hewlett Packard Enterprise is an industry leading technology company that enables customers to go further, faster. With the industry’s most comprehensive portfolio, spanning the cloud to the data center to workplace applications, our technology and services help customers around the world make IT more efficient, more productive and more secure.1 IDC Worldwide Semiannual Internet of Things Spending Guide, see https://www.idc.com/getdoc.jsp?containerId=prUS42799917

Contact information

ABB Ltd
Media Relations
Phone: +41 43 317 71 11
Email: media.relations@ch.abb.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Completes Resubmission to FDA for Proposed Trastuzumab Biosimilar18.6.2018 02:53Pressemelding

Celltrion (KRX:068270) has made a resubmission to the FDA (U.S. Food and Drug Administration) to obtain its marketing approval for CT-P6, a proposed mAb biosimilar to Herceptin® (trastuzumab). Celltrion submitted its abbreviated Biologics License Applications (aBLAs) for CT-P10 and CT-P6 to the FDA in April and May of last year, respectively. However, it received CRLs (complete response letters) from the FDA related to the warning letter issued by the FDA in January 2018, related to the manufacturing facility in Incheon, South Korea. Celltrion had completed the resubmission for the approval of CT-P10, a proposed biosimilar to Rituxan® (rituximab) last month. In accordance with FDA regulations, the approval procedure will be usually finalized within six months from the resubmission, so Celltrion expects the approval for the U.S. market of the two proposed biosimilars within this calendar year. FDA has notified Celltrion of its re-inspection schedule regarding regular audit results, and

CES Asia: Innovation at the Speed of 5G15.6.2018 14:59Pressemelding

CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019. “5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology re

bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association15.6.2018 10:00Pressemelding

bluebird bio, Inc. (Nasdaq: BLUE) today announced new interim data from the ongoing HGB-206 Phase 1 multicenter clinical study of LentiGlobin investigational gene therapy in patients with severe sickle cell disease (SCD) will be presented in an oral presentation on Saturday, June 16 at the 23rd Congress of the European Hematology Association (EHA) by Julie Kanter, M.D., Medical University of South Carolina, Charleston, South Carolina. “The consistent production of increased amounts of anti-sickling HbAT87Q in the Group C patients reflects the substantial positive impact of the changes introduced with the amended HGB-206 study protocol and refined manufacturing process. All four Group C patients with greater than or equal to three months follow-up are making over 30 percent anti-sickling HbAT87Q. The first patient treated, now with six months of follow-up, is producing over 60 percent anti-sickling HbAT87Q with a normal total hemoglobin level of 14.2 g/dL,” said David Davidson, M.D., ch

bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association15.6.2018 10:00Pressemelding

bluebird bio, Inc. (Nasdaq: BLUE) announced that new data from the completed Phase 1/2 Northstar (HGB-204) study in adolescents and adults with transfusion-dependent β-thalassemia (TDT) and any genotype, and its ongoing, Phase 3 Northstar-2 (HGB-207) multicenter clinical study of LentiGlobin™ investigational gene therapy in patients with TDT and non-β0/β0 genotypes, will be presented in an oral session on June 16 at the 23rd Annual Congress of the European Hematology Association by Franco Locatelli, M.D., Ph.D., of the IRCCS Ospedale Pediatrico Bambino Gesù of Rome, Italy. “The maturing data from HGB-204 and HGB-207 suggest that one-time treatment with LentiGlobin may address the underlying genetic cause of TDT. With our refined manufacturing process, the majority of patients with TDT and non-β0/β0 genotypes are transfusion-free and producing total hemoglobin at normal or near-normal levels,” said David Davidson, M.D., chief medical officer, bluebird bio. “We are on track to submit a m

AGP Group Announces the Acquisition of Soliver NV in Belgium, Representing a Key Step towards Becoming the Premier Global Leader in Designing and Manufacturing High-Tech Automotive Glazing15.6.2018 09:00Pressemelding

AGP, a high-tech specialty glass designer and manufacturer, has announced today the acquisition of Soliver NV, a European automotive glazing manufacturer with over 65 years of solid product and brand reputation. Soliver offers high-quality tempered and laminated glazing for high-end automobiles, as well as windshield solutions for trucks. AGP’s glazing heritage started in Berlin, with the Mannheim family´s first glass company. After 100 years and a clear vision to become a leader in specialty glass, AGP’s core eGlass technologies have responded to the rising demand in electrification, connectivity, shared mobility and autonomous driving, acting as an enabler of future mobility trends. The integration of Soliver into the AGP Group will strengthen the AGP eGlass value proposition and will be a game changer in a fast-evolving industry. “We are very excited to build upon Soliver’s great experience and track-record to take high-tech glazing to the next level, enabling our customer’s product

Rivoli Group announces completion of its new international corporate strategy15.6.2018 07:00Pressemelding

Rivoli Group AG completes its comprehensive operational restructuring process and acts with a new presence in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180615005085/en/ Rivoli Group Announces Completion of Its New International Corporate Strategy (Photo: Business Wire) The Swiss based Rivoli Group AG has now completed the comprehensive restructuring process as part of the international realignment of its corporate strategy. After an intensive evaluation of the situation, the available resources and existing market potential, the Chairman of the Board of Directors Mr. Mourad Malloul, the management team and an international advisory committee coordinated the strategy together. "This is the beginning of a crucial new chapter for the Rivoli Group," the President and CEO of Rivoli Group AG said. The measure aims to strengthen the competitive advantages within the company group, to adjust their service offerings